204 related articles for article (PubMed ID: 33781961)
41. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.
Sakanaka T; Inoue T; Yorifuji N; Iguchi M; Fujiwara K; Narabayashi K; Kakimoto K; Nouda S; Okada T; Kuramoto T; Ishida K; Abe Y; Takeuchi T; Umegaki E; Akiba Y; Kaunitz JD; Higuchi K
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1(Suppl 1):60-5. PubMed ID: 25827806
[TBL] [Abstract][Full Text] [Related]
42. Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability.
Liu J; Lin J; He S; Wu C; Wang B; Liu J; Duan Y; Liu T; Shan S; Yang K; Dong N; Ji Q; Huang K; Li D
Cell Physiol Biochem; 2018; 45(3):1034-1050. PubMed ID: 29439249
[TBL] [Abstract][Full Text] [Related]
43. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
[TBL] [Abstract][Full Text] [Related]
44. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells.
Komatsu T; Abe S; Nakashima S; Sasaki K; Higaki Y; Saku K; Miura SI; Uehara Y
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830597
[TBL] [Abstract][Full Text] [Related]
45. Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells.
Huang CY; Shih CM; Tsao NW; Lin YW; Huang PH; Wu SC; Lee AW; Kao YT; Chang NC; Nakagami H; Morishita R; Ou KL; Hou WC; Lin CY; Shyu KG; Lin FY
Br J Pharmacol; 2012 Dec; 167(7):1506-19. PubMed ID: 22788747
[TBL] [Abstract][Full Text] [Related]
46. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Shah Z; Kampfrath T; Deiuliis JA; Zhong J; Pineda C; Ying Z; Xu X; Lu B; Moffatt-Bruce S; Durairaj R; Sun Q; Mihai G; Maiseyeu A; Rajagopalan S
Circulation; 2011 Nov; 124(21):2338-49. PubMed ID: 22007077
[TBL] [Abstract][Full Text] [Related]
47. [Impact of CD137-CD137L signaling mediated exocytosis of autophagosome within vascular smooth muscle cells on the formation of atherosclerotic calcification].
Li B; Li XY; Zhong W; Shao C; Wang ZQ; Yuan W; Yan JC
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):49-56. PubMed ID: 28100346
[No Abstract] [Full Text] [Related]
48. Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model.
Gonçalves A; Leal E; Paiva A; Teixeira Lemos E; Teixeira F; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Diabetes Obes Metab; 2012 May; 14(5):454-63. PubMed ID: 22151893
[TBL] [Abstract][Full Text] [Related]
49. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
50. Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
Hernández C; Bogdanov P; Solà-Adell C; Sampedro J; Valeri M; Genís X; Simó-Servat O; García-Ramírez M; Simó R
Diabetologia; 2017 Nov; 60(11):2285-2298. PubMed ID: 28779212
[TBL] [Abstract][Full Text] [Related]
51. Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
Al-Awar A; Almási N; Szabó R; Takacs I; Murlasits Z; Szűcs G; Török S; Pósa A; Varga C; Kupai K
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340421
[TBL] [Abstract][Full Text] [Related]
52. VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis.
Li Y; Niu X; Xu H; Li Q; Meng L; He M; Zhang J; Zhang Z; Zhang Z
Exp Cell Res; 2020 Apr; 389(1):111847. PubMed ID: 31972218
[TBL] [Abstract][Full Text] [Related]
53. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
54. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
[TBL] [Abstract][Full Text] [Related]
56. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
Eitah HE; Maklad YA; Abdelkader NF; Gamal El Din AA; Badawi MA; Kenawy SA
Toxicol Appl Pharmacol; 2019 Feb; 365():30-40. PubMed ID: 30576699
[TBL] [Abstract][Full Text] [Related]
57. Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypepide, and dipeptidyl peptidase-4 inhibitors in experimental animals.
Hirano T; Mori Y
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):80-6. PubMed ID: 27186361
[TBL] [Abstract][Full Text] [Related]
58. DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.
Hu X; Liu S; Liu X; Zhang J; Liang Y; Li Y
Endocrine; 2017 Mar; 55(3):754-763. PubMed ID: 27612849
[TBL] [Abstract][Full Text] [Related]
59. Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.
Ansarullah ; Lu Y; Holstein M; DeRuyter B; Rabinovitch A; Guo Z
PLoS One; 2013; 8(1):e53345. PubMed ID: 23382843
[TBL] [Abstract][Full Text] [Related]
60. Combined use of GABA and sitagliptin promotes human β-cell proliferation and reduces apoptosis.
Liu W; Lau HK; Son DO; Jin T; Yang Y; Zhang Z; Li Y; Prud'homme GJ; Wang Q
J Endocrinol; 2021 Feb; 248(2):133-143. PubMed ID: 33258801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
